News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
21-Nov-2001 - Midland, Michigan and San Diego, California - November 19, 2001 - The Dow Chemical Company (NYSE: Dow) and Diversa Corporation (Nasdaq: DVSA) announced they have expanded their agreement to identify biocatalytic processes to replace traditional and costly multi-step chemical synthesis. The ...
01-Nov-2001 - In a move to consolidate its Midwestern operations, Albany Molecular Research, Inc. (Nasdaq: AMRI) today announced plans to relocate its Biocatalysis Division from Iowa City to the Chicago area, effective in 2002. Under the plan, AMRI's Biocatalysis Division, currently located in the University ...
17-Sep-2001 - Novartis scientists from around the world gathered at a research conference in Florence, Italy this week to report on new advances in genomics and disease knowledge and how the newest high-throughput technology, knowledge management and modeling tools are being used to improve and accelerate the ...
23-Aug-2001 - Eli Lilly and Company (NYSE: LLY) and Isis Pharmaceuticals, Inc. (NASDAQ: ISIP) announced today that they have entered into a strategic alliance that includes the license of Isis' novel antisense cancer compound and the formation of a broad collaboration to discover antisense drugs. The ...
Aventis highlights network-centric approach at press briefing in Boston
20-Aug-2001 - Drug discovery in the post-genome era will be more complex than ever before, and only a network-centric approach to drug discovery will meet the new complexity challenge, Aventis executives told science writers at a press briefing on Tuesday on occasion of the Drug Technology Conference in ...
14-Aug-2001 - Aventis Pharmaceuticals, Inc. the pharmaceutical company of Aventis (NYSE: AVE) and Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that they have expanded their joint development pipeline to include 11 discovery projects that were previously being pursued outside the joint ...
13-Jul-2001 - Drug Screening Technology from U.K.’s Protherics Adding "Virtual" to Existing "Physical" High-Throughput Screening Capabilities Is Expected to Boost the Number and Quality of Drug Leads South San Francisco, Calif., July 12, 2001 -- Tularik (Nasdaq: TLRK) announced today that it acquired ...
15-May-2001 - Data from a Phase II study presented today at the annual meeting of the American Society of Clinical Oncology (ASCO) showed that atrasentan (ABT-627), Abbott Laboratories' investigational endothelin-A receptor antagonist, significantly delayed the progression of hormone-refractory prostate ...
27-Mar-2001 - San Diego, CA, March 22, 2001 - Maxim Pharmaceuticals (Nasdaq NM: MAXM, SSE: MAXM) announced today that the United States Patent & Trademark Office has issued the Company two new patents that support the Company's caspase modulator technology for the treatment of a diverse set of degenerative ...
02-Mar-2001 - BASF is the first company to decipher the genetic information of the bacterium Corynebacterium glutamicum and has applied for comprehensive patent protection. This was achieved in cooperation with the biotechnology company Integrated Genomics, Inc., Chicago. The partners have also determined ...
© 1997-2024 LUMITOS AG, All rights reserved